
AAVs are widely studied therapeutic gene delivery vectors. However, preexisting antibodies and their detrimental effect on therapeutic efficacy are a primary challenge encountered during clinical trials.
Models, Molecular, 570, receptor, Genetic Vectors, 610, adeno-associated virus, CHO Cells, Cross Reactions, Adeno-Associated Virus, Parvovirus, Sialic Acid, Epitopes, Capsid, Cricetulus, antibody, Cricetinae, capsid, Animals, Humans, Antibody, Cryo-EM, parvovirus, Cryoelectron Microscopy, AAV, Gene Therapy, Dependovirus, gene therapy, N-Acetylneuraminic Acid, sialic acid, Human Sera, cryo-EM, Capsid Proteins, Receptor, human sera
Models, Molecular, 570, receptor, Genetic Vectors, 610, adeno-associated virus, CHO Cells, Cross Reactions, Adeno-Associated Virus, Parvovirus, Sialic Acid, Epitopes, Capsid, Cricetulus, antibody, Cricetinae, capsid, Animals, Humans, Antibody, Cryo-EM, parvovirus, Cryoelectron Microscopy, AAV, Gene Therapy, Dependovirus, gene therapy, N-Acetylneuraminic Acid, sialic acid, Human Sera, cryo-EM, Capsid Proteins, Receptor, human sera
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 19 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
